Taysha Gene Therapies, Inc. (TSHA) Discusses Longer-Term Clinical Data and Program Update for TSHA-102 in Rett Syndrome Transcript

Seeking Alpha•Mon, Jun 22, 2026, 08:42 PM•2 min read

Developing story — details emerging. Check the source link for the latest updates.

Source: [Seeking Alpha](https://seekingalpha.com/article/4916763-taysha-gene-therapies-inc-tsha-discusses-longer-term-clinical-data-and-program-update-for?source=feed_all_articles)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

Continue Reading at Seeking Alpha ↗

#finance #tsha #taysha #gene #therapies #inc #discusses #longer #term

More Headlines

FinanceCNBC• 6m ago

'We'll see' — Trump hedges on guarantee Iran won't use oil profits to rebuild military

Treasury Secretary Scott Bessent authorized the import of Iranian oil and refined products into the U. S. through at least August.

FinanceInvesting.com• 9m ago

Jared Moskowitz from Florida’s 23rd District Trades in Cencora and Gilead Sciences Stocks

Developing story — details emerging. Check the source link for the latest updates.

FinanceSeeking Alpha• 10m ago

Thule Group AB (publ) (THUPY) Discusses Pre-Quarter Update, Growth in Champion Product Categories, and Recent Acquisition in Dog Transportation - Slideshow

Developing story — details emerging. Check the source link for the latest updates.

FinanceSeeking Alpha• 10m ago

Gold Royalty Corp. (GROY) Analyst/Investor Day - Slideshow

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 11m ago

Miami International Holdings reports unregistered stock issuances and warrant exchanges

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 11m ago

Mara Holdings general counsel Zabi sells $99,750 in stock

Developing story — details emerging. Check the source link for the latest updates.